Printer Friendly

FISCHER IMAGING FILES A PATENT INFRINGEMENT LAWSUIT

 FISCHER IMAGING FILES A PATENT INFRINGEMENT LAWSUIT
 DENVER, Colo., April 2 /PRNewswire/ -- Fischer Imaging Corp.


(NASDAQ: FIMG) today filed a lawsuit for patent infringement against LORAD Corp. in the United States District Court for the District of Colorado.
 Fischer, a developer and manufacturer of mammography systems, owns United States Patent 5,078,142 covering certain features of its MAMMOTEST(TM) stereotactic breast biopsy system. The MAMMOTEST(TM) system provides prone positioning for the patient, which the company believes is both safer for the patient and permits more accurate needle placement than a breast biopsy with the patient in a sitting or standing position. The MAMMOTEST(TM) system is less invasive and procedures can be performed at approximately one-third the cost of a surgical biopsy with equivalent accuracy.
 LORAD, a Connecticut based corporation, has recently introduced a mammographic biopsy system which Fischer believes infringes certain claims of its patent. Fischer notified LORAD of its patent rights on Feb. 14, 1992. Despite such notice, LORAD has continued to sell its system.
 Fischer is seeking to permanently enjoin LORAD and its officers and agents from the manufacturer, use and sale of LORAD's allegedly infringing mammography system. Moreover, Fischer is seeking to recover trebled damages and attorney fees, the sum of which is yet to be determined, based upon LORAD's infringing activities.
 Morgan W. Nields, chairman and chief executive officer of Fischer Imaging, stated, "We have spent many years and several million dollars developing a prone positioning stereotactic breast biopsy system and proving the efficacy of the prone technique in clinical trials. We believe that LORAD has, without regard to our patent on the MAMMOTEST(TM), copied certain patented features of our system. We intend to vigorously enforce our patent rights against LORAD or any other potential infringer."
 Fischer Imaging designs, manufactures and markets specialty and general purpose x-ray imaging systems for the diagnosis and treatment of breast cancer, heart and vascular disease. The company's newest product lines are directed towards medical specialties in which minimally invasive surgical techniques are replacing open surgical procedures.
 -0- 4/2/92
 /CONTACT: Roberto A. Cascella of Fischer Imaging Corp., 303-452-6800; or Scott A. Brooks of Carl Thompson & Associates, 303-494-5472, for Fischer Imaging/
 (FIMG) CO: Fischer Imaging Corp. ST: Colorado IN: HEA MTC SU:


MC -- DV001 -- 4422 04/02/92 13:19 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 2, 1992
Words:385
Previous Article:SNO COUNTRY REPORTS OFFICIAL SKI REPORT FOR APRIL 2, 1992
Next Article:KIRBY COMPLETES PURCHASE


Related Articles
MOLECULAR BIOSYSTEMS INC. AND SYNGENE INC. COMMENT ON GEN-PROBE PATENT SUIT
FISCHER IMAGING REPORTS RECORD SECOND QUARTER EARNINGS AND REVENUES
INTERDIGITAL TECHNOLOGY RESPONDS TO ERICSSON LAWSUIT
GENERAL INSTRUMENT CORPORATION TO TAKE ACTION AGAINST COMSAT CORPORATION FOR 'ERRONEOUS' LITIGATION
Fischer Imaging Announces Receipt of a New Patent and Filing of Patent Suit Against Trex Medical Corporation
Storm Technology Files CIS Patent-Infringement Lawsuit Against Ultima International/Artec.
Macromedia Files Patent Infringement Counterclaims Against Adobe Systems.
Xenogen Files Answer and Counterclaims in Patent Infringement Litigation with AntiCancer Inc.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters